Determination of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, in umbilical blood

Metabolism: Clinical and Experimental

Volumn 57, Issue 2, 2008, Pages 215-220

  Tsukahara, Hirokazu ^a   Ohta, Naoko ^a   Tokuriki, Shuko ^a   Nishijima, Koji ^a   Kotsuji, Fumikazu ^a   Kawakami, Hisako ^b   Ohta, Norihito ^b   Sekine, Kyouichi ^b   Nagasaka, Hironori ^c   Mayumi, Mitsufumi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c CHIBA CHILDREN'S HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; BLOOD VESSEL TONE; CHILD; CHORIOAMNIONITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; MALE; NEWBORN; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOLUTIO PLACENTAE; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; ARGININE; CHILD; CHILD, PRESCHOOL; ENZYME INHIBITORS; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LINEAR MODELS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; PREGNANCY; UMBILICAL VEINS;

EID: 38049082989     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.09.003     Document Type: Article

References (29)

1. Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109-142
2. Goligorsky M.S. Endothelial cell dysfunction: can't live with it, how to live without it. Am J Physiol Renal Physiol 288 (2005) F871-F880
3. Cooke J.P. ADMA: its role in vascular disease. Vasc Med 10 (2005) S11-S17
4. Leiper J.M., and Vallance P. The synthesis and metabolism of asymmetric dimethylarginine (ADMA). Eur J Clin Pharmacol 62 (2006) 33-38
5. Zoccali C., and Kielstein J.T. Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?. Curr Opin Nephrol Hypertens 15 (2006) 314-320
6. Slaghekke F., Dekker G., and Jeffries B. Endogenous inhibitors of nitric oxide and preeclampsia: a review. J Matern Fetal Neonatal Med 19 (2006) 447-452
7. Maeda T., Yoshimura T., and Okamura H. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, in maternal and fetal circulation. J Soc Gynecol Investig 10 (2003) 2-4
8. Mittermayer F., Prusa A.R., Pollak A., et al. Umbilical vein plasma concentrations of asymmetrical dimethylarginine are increased in male but not female neonates delivered preterm: a pilot study. Early Hum Dev 82 (2006) 421-424
9. Vida G., Sulyok E., Ertl T., et al. Plasma asymmetric dimethylarginine concentration during the perinatal period. Neonatology 92 (2007) 8-13
10. Schulze F., Wesemann R., Schwedhelm E., et al. Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 42 (2004) 1377-1383
11. G-dimethyl-l-arginine in 500 subjects. Eur J Clin Invest 35 (2005) 622-626
12. Tsukahara H., Sekine K., Miura M., et al. Vasoactive and natriuretic mediators in umbilical cord blood: a report of our observation and review of the literature. Early Hum Dev 69 (2002) 57-64
13. Kielstein J.T., Tsikas D., and Fliser D. Effects of asymmetric dimethylarginine (ADMA) infusion in humans. Eur J Clin Pharmacol 62 (2006) 39-44
14. Schwedhelm E. Quantification of ADMA: analytical approaches. Vasc Med 10 (2005) S89-S95
15. Arrigoni F.I., Vallance P., Haworth S.G., et al. Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia. Circulation 107 (2003) 1195-1201
16. Endo A., Shimada M., Ayusawa M., et al. Nitric oxide and endothelin 1 during postnatal life. Biol Neonate 70 (1996) 15-20
17. Endo A., Izumi H., Ayusawa M., et al. Spontaneous labor increases nitric oxide synthesis during the early neonatal period. Pediatr Int 43 (2001) 340-342
18. Biban P., Zangardi T., Baraldi E., et al. Mixed exhaled nitric oxide and plasma nitrites and nitrates in newborn infants. Life Sci 68 (2001) 2789-2797
19. Ellis J., Wennerholm U.B., Bengtsson A., et al. Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 80 (2001) 602-608
20. Savvidou M.D., Hingorani A.D., Tsikas D., et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361 (2003) 1511-1517
21. Maas R., Boger R.H., Schwedhelm E., et al. Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia. JAMA 291 (2004) 823-824
22. Mugo M., Govindarajan G., Kurukulasuriya L.R., et al. Hypertension in pregnancy. Curr Hypertens Rep 7 (2005) 348-354
23. Poston L. Endothelial dysfunction in pre-eclampsia. Pharmacol Rep 58 (2006) S69-S74
24. Leiper J., Murray-Rust J., McDonald N., et al. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci U S A 99 (2002) 13527-13532
25. Dayoub H., Achan V., Adimoolam S., et al. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation 108 (2003) 3042-3047
26. Ueda S., Kato S., Matsuoka H., et al. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circ Res 92 (2003) 226-233
27. Billecke S.S., Kitzmiller L.A., Northrup J.J., et al. Contribution of whole blood to the control of plasma asymmetrical dimethylarginine. Am J Physiol Heart Circ Physiol 291 (2006) H1788-H1796
28. Seri I., and Noori S. Diagnosis and treatment of neonatal hypotension outside the transitional period. Early Hum Dev 81 (2005) 405-411
29. Perreault T. Persistent pulmonary hypertension of the newborn. Paediatr Respir Rev 7 (2006) S175-S176